Showing 1 to 3 of 3 results


Genital Herpes: 846 Million Infections, Rising Rates, and the Urgent Need for New Treatments
Globally, 846 million people aged 15-49 have genital herpes, with 42 million new infections yearly; rates are rising for HSV-1 in developed nations due to delayed childhood exposure, while dropping in sub-Saharan Africa due to HIV/AIDS interventions.
Genital Herpes: 846 Million Infections, Rising Rates, and the Urgent Need for New Treatments
Globally, 846 million people aged 15-49 have genital herpes, with 42 million new infections yearly; rates are rising for HSV-1 in developed nations due to delayed childhood exposure, while dropping in sub-Saharan Africa due to HIV/AIDS interventions.
Progress
24% Bias Score


WHO: 1 in 5 under 50 Have Genital Herpes, Highlighting Urgent Need for Vaccine
WHO estimates reveal that 1 in 5 people under 50 globally have genital herpes, with HSV-2 causing the vast majority of the 204.6 million genital ulcer cases in 2020; this necessitates vaccine development to address the $35 billion annual economic burden and the increased HIV transmission risk.
WHO: 1 in 5 under 50 Have Genital Herpes, Highlighting Urgent Need for Vaccine
WHO estimates reveal that 1 in 5 people under 50 globally have genital herpes, with HSV-2 causing the vast majority of the 204.6 million genital ulcer cases in 2020; this necessitates vaccine development to address the $35 billion annual economic burden and the increased HIV transmission risk.
Progress
36% Bias Score

WHO Report: One in Five Under 50 Have Genital Herpes, Highlighting Urgent Need for Vaccine
A new WHO report reveals that one in five people under 50 globally have genital herpes, with HSV-2 being the primary cause, resulting in a significant global economic burden of $35 billion annually and highlighting the urgent need for a vaccine.

WHO Report: One in Five Under 50 Have Genital Herpes, Highlighting Urgent Need for Vaccine
A new WHO report reveals that one in five people under 50 globally have genital herpes, with HSV-2 being the primary cause, resulting in a significant global economic burden of $35 billion annually and highlighting the urgent need for a vaccine.
Progress
36% Bias Score
Showing 1 to 3 of 3 results